Bayer enhances leadership roles for D Narain, Simon Thorsten Wiebusch

Published On 2022-01-11 08:01 GMT   |   Update On 2022-01-11 08:01 GMT
Click the Play button to listen to article

New Delhi: Global pharma and chemicals major Bayer on Monday said it has enhanced leadership roles for two senior executives from India team — D Narain and Simon Thorsten Wiebusch.

D Narain, who is currently president of Bayer South Asia and MD of Bayer CropScience Ltd, will take on additional leadership responsibilities as global head of smallholder farming for Bayer, the company said in a statement.

Advertisement

Germany-based Bayer, a global life sciences company present in India for over 125 years, said the decision has been taken to support its strong commitment to improve the livelihood of 100 million smallholders globally and deliver sustainable farming solutions.

Simon Thorsten Wiebusch, who is currently the chief operating officer of Bayer's CropScience business for India, Bangladesh, and Sri Lanka (IBSL), takes over as the executive director of Bayer CropScience Ltd and the country divisional head of the crop science business in these countries.

D Narain and Simon will continue to be based out of India, which is the largest small farmer market in the world.

Read also: Cadila Healthcare, Bayer to extend JV Bayer Zydus Pharma by 3 years

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.

In the financial year 2019-20, the Group employed around one lakh people and had sales of 41.4 billion euros.

Read also: Bayer Finerenone gets USFDA approval to treat CKD associated with type 2 diabetes

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News